The virtual biopsy prototype device can distinguish between healthy skin and different types of skin lesions and carcinomas.
Rutgers University
Using sound vibrations and pulses of near-infrared light, a Rutgers University scientist has developed a new “virtual biopsy” device that can quickly determine a skin lesion’s depth and potential malignancy without using a scalpel.
The ability to analyze a skin tumor non-invasively could make biopsies much less risky and distressing to patients, according to a report in Wiley Online Library. Currently, physicians who perform surgical biopsies often don’t know the extent of a lesion – and whether it will be necessary to refer the patient to a specialist for extensive tissue removal or plastic surgery – until surgery has already begun.
The first-of-its-kind experimental procedure, called vibrational optical coherence tomography (VOCT), creates a 3-D map of the legion’s width and depth under the skin with a tiny laser diode. It also uses soundwaves to test the lesion’s density and stiffness since cancer cells are stiffer than healthy cells. An inch-long speaker applies audible soundwaves against the skin to measure the skin’s vibrations and determine whether the lesion is malignant.
“This procedure can be completed in 15 minutes with no discomfort to the patient, who feels no sensation from the light or the nearly inaudible sound. It’s a significant improvement over surgical biopsies, which are invasive, expensive and time consuming,” said lead researcher Frederick Silver, a professor of pathology and laboratory medicine at Rutgers Robert Wood Johnson Medical School.
The study found that a prototype VOCT device, which awaits FDA approval for large-scale testing, is able to accurately distinguish between healthy skin and different types of skin lesions and carcinomas. The researchers tested the device over six months on four skin excisions and on eight volunteers without skin lesions. Further studies are needed to fine-tune the device’s ability to identify a lesion’s borders and areas of greatest density and stiffness, which would allow physicians to remove tumors with minimally invasive surgery.
Learn more: Rutgers Scientist Creates “Virtual Biopsy” Device to Detect Skin Tumors
The Latest on: Non-invasive biopsy
via Google News
The Latest on: Non-invasive biopsy
- PATRIOT MINEFINDERS (PROF) Q4 2020 Earnings Call Transcripton March 3, 2021 at 8:00 am
Q4 2020 Earnings CallMar 02, 2021, 4:30 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Ladies and gentlemen, thank you for standing by and ...
- Agilent Adds Liquid Biopsy Assayon March 2, 2021 at 1:07 pm
Agilent Technologies, expanding on the company's precision oncology testing, is acquiring Resolution Bioscience.
- Agilent to Acquire Resolution Bioscience, Strengthening Leadership Position in Cancer Diagnosticson March 2, 2021 at 5:18 am
Resolution Bioscience is a fast-growing, innovative leader in next-generation sequencing (NGS)-based oncology solutions. Combination brings together Resolution Bioscience’s noninvasive liquid biopsy ...
- Researchers confirm a threshold value for non-invasive imaging biomarkeron March 1, 2021 at 9:36 pm
Breast cancer is the commonest fatal cancer in women. Early detection increases a woman's chances of recovery. Magnetic Resonance Imaging (MRI) is an accurate technique for detecting and classifying ...
- Breast cancer screening recalls: simple MRI measurement could avoid 30% of biopsieson February 28, 2021 at 9:00 pm
Magnetic Resonance Imaging (MRI) is an accurate technique for detecting and classifying tumours in breast tissue. However, it sometimes causes ''false alarms'', thus requiring further investigation ...
- Simple MRI measurement could avoid 30% of breast cancer biopsieson February 28, 2021 at 4:00 pm
Breast cancer is the most common fatal cancer in women. Early detection increases a woman's chances of recovery. Magnetic resonance imaging (MRI) is an accurate technique for detecting and classifying ...
- Ovation Fertility Releases Preliminary Findings of Ongoing Non-Invasive PGT-A Studyon February 28, 2021 at 3:02 am
Ovation® Fertility’s Genetics program has released the initial findings of its ongoing study of non-invasive preimplantation genetic testing for aneuploidy (PGT-A). PGT-A is used to identify ...
- Molecular Stethoscope Announces Publication of its NAFLD/NASH Study in the American Journal of Physiology - Gastrointestinal and Liver Physiologyon February 23, 2021 at 12:21 am
"Once validated in larger studies, non-invasive Liquid Biopsy diagnostic solutions such as the ones being developed by Molecular Stethoscope may be used serially not only as Drug Development Tools ...
- Molecular Stethoscope Announces Publication of its NAFLD/NASH Study in the American Journal of Physiology - Gastrointestinal and Liver Physiologyon February 23, 2021 at 12:00 am
"Once validated in larger studies, non-invasive Liquid Biopsy diagnostic solutions such as the ones being developed by Molecular Stethoscope may be used serially not only as Drug Development Tools to ...
- TARGET-NASH Real-World Study Reveals Two Thirds Of Patients With NAFLD Had No Record Of Liver Biopsyon February 22, 2021 at 7:32 am
Target RWE, a leading real-world evidence (RWE) solutions company for the pharmaceutical and biotech industries, announced newest data from its ongoing nonalcoholic steatohepatitis (NASH) ...
via Bing News